DE68922478D1 - Pyrazoloisoquinoline-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen. - Google Patents
Pyrazoloisoquinoline-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen.Info
- Publication number
- DE68922478D1 DE68922478D1 DE68922478T DE68922478T DE68922478D1 DE 68922478 D1 DE68922478 D1 DE 68922478D1 DE 68922478 T DE68922478 T DE 68922478T DE 68922478 T DE68922478 T DE 68922478T DE 68922478 D1 DE68922478 D1 DE 68922478D1
- Authority
- DE
- Germany
- Prior art keywords
- optionally substituted
- cycloalkyl
- processes
- preparation
- substituted phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- PGUJOAOYKQFMHB-UHFFFAOYSA-N 3h-pyrazolo[3,4-h]isoquinoline Chemical class C1=NC=C2C3=CNN=C3C=CC2=C1 PGUJOAOYKQFMHB-UHFFFAOYSA-N 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 6
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 5
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 4
- 229910052739 hydrogen Inorganic materials 0.000 abstract 4
- 239000001257 hydrogen Substances 0.000 abstract 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 150000002431 hydrogen Chemical class 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 1
- 210000003169 central nervous system Anatomy 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB888828669A GB8828669D0 (en) | 1988-12-08 | 1988-12-08 | Organic compounds |
Publications (2)
Publication Number | Publication Date |
---|---|
DE68922478D1 true DE68922478D1 (de) | 1995-06-08 |
DE68922478T2 DE68922478T2 (de) | 1997-02-06 |
Family
ID=10648173
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE68922478T Expired - Fee Related DE68922478T2 (de) | 1988-12-08 | 1989-12-07 | Pyrazoloisoquinoline-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen. |
Country Status (8)
Country | Link |
---|---|
US (1) | US4963558A (de) |
EP (1) | EP0375210B1 (de) |
JP (1) | JPH02202887A (de) |
AT (1) | ATE122042T1 (de) |
CA (1) | CA2004826A1 (de) |
DE (1) | DE68922478T2 (de) |
ES (1) | ES2071666T3 (de) |
GB (1) | GB8828669D0 (de) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2038077B1 (es) * | 1991-10-07 | 1994-02-01 | Univ Alcala Henares | Procedimiento de obtencion de antibioticos y citostaticos pirazoloisoquinolinicos. |
GB9911053D0 (en) | 1999-05-12 | 1999-07-14 | Pharmacia & Upjohn Spa | 4,5,6,7-tetrahydroindazole derivatives process for their preparation and their use as antitumour agents |
NZ550362A (en) | 2004-03-09 | 2010-06-25 | Corcept Therapeutics Inc | Fused ring azadecalin glucocorticoid receptor modulators |
CA2806900A1 (en) | 2010-08-27 | 2012-03-01 | Corcept Therapeutics, Inc. | Pyridyl-amine fused azadecalin modulators |
CN103298343A (zh) | 2011-01-07 | 2013-09-11 | 科赛普特治疗公司 | 类固醇和糖皮质激素受体拮抗剂组合疗法 |
US20130225633A1 (en) * | 2012-02-27 | 2013-08-29 | Corcept Therapeutics, Inc. | Phenyl heterocycloalkyl glucocorticoid receptor modulators |
US8859774B2 (en) | 2012-05-25 | 2014-10-14 | Corcept Therapeutics, Inc. | Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators |
PT3851107T (pt) | 2012-05-25 | 2022-10-28 | Corcept Therapeutics Inc | Moduladores de recetores de glucocorticoides de azadecalina fundida com heteroaril-cetona |
KR102352737B1 (ko) * | 2013-11-25 | 2022-01-17 | 코어셉트 쎄라퓨틱스 인코포레이티드 | 옥타하이드로 융합된 아자데칼린 글루코코르티코이드 수용체 조절제 |
MX2019011543A (es) | 2017-03-31 | 2019-12-16 | Corcept Therapeutics Inc | Moduladores del receptor de glucocorticoides para el tratamiento de cancer cervical. |
US11234971B2 (en) | 2018-12-19 | 2022-02-01 | Corcept Therapeutics Incorporated | Methods of treating cancer comprising administration of a glucocorticoid receptor modulator and a cancer chemotherapy agent |
WO2020132046A1 (en) | 2018-12-19 | 2020-06-25 | Corcept Therapeutics Incorporated | Methods of treating cancer comprising administration of a glucocorticoid receptor modulator and a cancer chemotherapy agent |
BR112021010461A2 (pt) | 2018-12-19 | 2021-08-24 | Corcept Therapeutics Incorporated | Formulação e dose unitária para administração oral de relacorilante |
SG11202108964YA (en) | 2019-02-22 | 2021-09-29 | Corcept Therapeutics Inc | Therapeutic uses of relacorilant, a heteroaryl-ketone fused azadecalin glucocorticoid receptor modulator |
EP4072556A4 (de) | 2019-12-11 | 2024-01-03 | Corcept Therapeutics Inc | Verfahren zur behandlung von antipsychotikainduzierter gewichtszunahme mit miricorilant |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1132553A (en) * | 1978-10-13 | 1982-09-28 | Gary L. Olson | Isoquinoline derivatives |
US4230861A (en) * | 1979-01-22 | 1980-10-28 | Eli Lilly And Company | 1-And/or 7-substituted-6-hydroxy (or oxo)-3-decahydroquinoline carboxylic acids |
US4468401A (en) * | 1982-11-03 | 1984-08-28 | Eli Lilly And Company | Method of blocking peripheral norepinephrine release |
CA1270488A (en) * | 1983-09-26 | 1990-06-19 | John M. Schaus | Pyrazole-ring alkylated pyrazoloquinolines and intermediates |
US4596871A (en) * | 1983-09-26 | 1986-06-24 | Eli Lilly And Company | Pyrazole-ring alkylated pyrazoloquinolines |
US4762843A (en) * | 1986-09-15 | 1988-08-09 | Warner-Lambert Company | Hetero [f] fused carbocyclic pyridines as dopaminergic agents |
-
1988
- 1988-12-08 GB GB888828669A patent/GB8828669D0/en active Pending
-
1989
- 1989-12-07 AT AT89312761T patent/ATE122042T1/de not_active IP Right Cessation
- 1989-12-07 CA CA002004826A patent/CA2004826A1/en not_active Abandoned
- 1989-12-07 ES ES89312761T patent/ES2071666T3/es not_active Expired - Lifetime
- 1989-12-07 DE DE68922478T patent/DE68922478T2/de not_active Expired - Fee Related
- 1989-12-07 US US07/447,319 patent/US4963558A/en not_active Expired - Fee Related
- 1989-12-07 EP EP89312761A patent/EP0375210B1/de not_active Expired - Lifetime
- 1989-12-08 JP JP1320356A patent/JPH02202887A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
ES2071666T3 (es) | 1995-07-01 |
ATE122042T1 (de) | 1995-05-15 |
EP0375210A1 (de) | 1990-06-27 |
US4963558A (en) | 1990-10-16 |
CA2004826A1 (en) | 1990-06-08 |
JPH02202887A (ja) | 1990-08-10 |
EP0375210B1 (de) | 1995-05-03 |
DE68922478T2 (de) | 1997-02-06 |
GB8828669D0 (en) | 1989-01-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69030206D1 (de) | Pyrazolopyridinverbindungen und Verfahren zu ihrer Herstellung | |
ATE139232T1 (de) | Bizyklische pyrimidinderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung | |
ATE175201T1 (de) | Mono-n-substituierte 1,4,7,10- tetraazacyclododecan-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel | |
DE68922478T2 (de) | Pyrazoloisoquinoline-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen. | |
ATE71375T1 (de) | Substituierte 6-fluor-4-oxo-1,4-dihydrochinolin-3-carbonsaeure ; deren derivate; diese verbindung enthaltende pharmazeutische zubereitungen und verfahren zur herstellung dieser verbindungen. | |
PT76450A (de) | Spiro/4.(3+n)-2-aza-3-carbonsaeure-derivate verfahren zu ihrer herstellung diese enthaltende mittel und ihre verwendung | |
DE69310602T2 (de) | 3',5'-Ditertbutyl-4'-Hydroxyflavone, Verfahren zu ihrer Herstellung und pharmazeutische Zusammensetzung mit Antioxidations- und Antivasokonstriktionsaktivität | |
DE69231817D1 (de) | Carbamatderivate von 4-Amino-3-Isoxazolidinonen und 3-Amino-1-Hydroxypyrrolidinon-2-onen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel | |
ATE18549T1 (de) | 1-carboxyalkanoylindolin-2-carbonsaeure-ester, verfahren zu ihrer herstellung, pharmazeutische praeparate enthaltend diese verbindungen, sowie ihre therapeutische verwendung. | |
DE69116237T2 (de) | Derivate von Hexahydroazepine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel | |
DE59305012D1 (de) | 4-Amino-2-ureido-pyrimidin-5-carbonsäureamide, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung | |
DE69217613D1 (de) | Stickstoff enthaltende bizyklische Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen | |
DE69300296T2 (de) | Thiochromanderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen. | |
CA2038025A1 (en) | Optically active alkylenedioxybenzene derivatives and their use in therapy | |
ATE53209T1 (de) | Piperazinverbindungen, verfahren zu ihrer herstellung, pharmazeutische zusammensetzung und verwendung. | |
DE69300197T2 (de) | Aminoalkylchromone, Verfahren zu ihrer Herstellung und diese enthaltende Zusammensetzungen. | |
DE69300011T2 (de) | Diacylglycerol-Nicotinate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen. | |
DE202441T1 (de) | Oxadiazolylimidazobenzodiazepine, verfahren zu ihrer herstellung und pharmazeutische zubereitungen. | |
DE3675277D1 (de) | Catechinamide, verfahren zu ihrer herstellung, zwischenprodukte und pharmazeutische zubereitung. | |
DE68922596T2 (de) | 3-(3-Ethyl-1,2,4-oxadiazol-5-yl)-1-azabicycloheptan, Verfahren zu seiner Herstellung und dieses enthaltende pharmazeutische Zubereitungen. | |
ATE82289T1 (de) | 1-hydroxyalkylxanthine, verfahren zu ihrer herstellung und sie enthaltende medikamente. | |
DE69400283D1 (de) | (Cyclohexyl)alkenderivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen | |
ATE85609T1 (de) | S-difluoromethylhomocysteine, verfahren zu ihrer herstellung und insektizide zusammensetzungen. | |
ZA933942B (en) | Pyrrolothienopyrazine compounds, processes for the preparation thereof and pharmaceutical compositions containing them | |
IT1224404B (it) | Composti attivi sul sistema cardiovascolare |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8327 | Change in the person/name/address of the patent owner |
Owner name: LILLY INDUSTRIES LTD., BASINGSTOKE, HAMPSHIRE, GB |
|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |